ClinicalTrials.gov
public full text
Public Domain
Japanese BAY1000394 Monotherapy Phase I Study
This is an open-label, non-randomized, dose-escalating Phase I study to evaluate the safety, tolerability, pharmacokinetics of BAY1000394 given in a 3 days on / 4 days off schedule in Japanese subjects with advanced malignancies.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Japanese BAY86-9766 Monotherapy Phase I Study#855421
- First in Human Study of M1069 in Advanced Solid Tumors#1170930
- Phase I Dose Escalation of BAY1143572 in Subjects With Acute Leukemia#1085583
- A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of RCZY690 in Advanced Solid Tumors#967099
- Phase I Study of the BBP-398 in Patients With Advance Solid Tumors#1031604
Record · ID 911172
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive